An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

Joel C. WightDepartment of Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, Australia; Correspondence[email protected]

Eliza A. HawkesDepartment of Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, Australia; ;Faculty of Health Sciences, Olivia Newton John Cancer Research Institute, La Trobe University, Heidelberg, Australia; ;Faculty of Health Sciences, Monash University, Melbourne, Australia; ;Department of Oncology, Eastern Health, Box Hill, Australia;

Salvatore U. BerlangieriDepartment of Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, Australia;

Richard KhorDepartment of Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;Faculty of Health Sciences, University of Melbourne, Melbourne, Australia

Andrew P. GriggDepartment of Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, Australia; ;Faculty of Health Sciences, University of Melbourne, Melbourne, Australia

References

Younes A, Santoro A, Shipp M, et al. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. Lancet Oncol. 2016;17:1283–1294.
PubMed Web of Science ®Google Scholar
Chen R, Zinzani PL, Fanale MA, et al. Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma. J Clin Oncol. 2017;35:2125–2132.
PubMed Web of Science ®Google Scholar
Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10:718–726.
PubMed Web of Science ®Google Scholar
Park SS, Dong H, Liu X, et al. PD-1 restrains radiotherapy-induced abscopal effect. Cancer Immunol Res. 2015;3:610–619.
PubMed Web of Science ®Google Scholar
Pilones KA, Vanpouille-Box C, Demaria S. Combination of radiotherapy and immune checkpoint inhibitors. Semin Radiat Oncol. 2015;25:28–33.
PubMed Web of Science ®Google Scholar
Michot JM, Mazeron R, Dercle L, et al. Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody. Eur J Cancer. 2016;66:91–94.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date